<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00898482</url>
  </required_header>
  <id_info>
    <org_study_id>JHOC-J0533 CDR0000452792</org_study_id>
    <secondary_id>P30CA006973</secondary_id>
    <secondary_id>JHOC-J0533</secondary_id>
    <secondary_id>JHOC-05042601</secondary_id>
    <nct_id>NCT00898482</nct_id>
  </id_info>
  <brief_title>Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants</brief_title>
  <official_title>Pancreatic Cancer Serum and Peripheral Blood Lymphocyte Repository</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Collecting and storing samples of blood from patients with cancer and healthy
      participants to test in the laboratory may help the study of cancer in the future.

      PURPOSE: This study is collecting and storing samples of blood from patients with pancreatic
      cancer and healthy participants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Establish a central pancreatic cancer specimen (including serum and peripheral blood
           lymphocytes) repository to serve as a resource for current or future scientific studies.

        -  Utilize the clinical database to perform clinicopathologic correlation with the results
           of those studies.

        -  Test new hypotheses as they emerge.

      OUTLINE: This is a prospective study.

      Blood is collected from patients with pancreatic cancer at baseline and then every 3-6 months
      for up to 2 years. All other participants have blood collected at baseline and complete
      questionnaires at baseline and then every 3-6 months for up to 2 years. Serum and peripheral
      blood lymphocytes obtained from the blood samples are frozen and stored.

      PROJECTED ACCRUAL: A total of 200 patients and 200 other participants will be accrued for
      this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Establishment of a central pancreatic cancer specimen repository</measure>
    <time_frame>No time frame</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Utilization of the clinical database to perform clinicopathologic correlation with the results of current or future scientific studies</measure>
    <time_frame>No time frame</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Test new hypotheses as they emerge</measure>
    <time_frame>No time frame</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">88</enrollment>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>Healthy individuals</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>At risk individuals</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Cancer patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>This is a non-intervention study for all groups.</intervention_name>
    <description>This is a non-intervention study.</description>
    <arm_group_label>Healthy individuals</arm_group_label>
    <arm_group_label>At risk individuals</arm_group_label>
    <arm_group_label>Cancer patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>study of socioeconomic and demographic variables</intervention_name>
    <description>Non-intervention study.</description>
    <arm_group_label>Healthy individuals</arm_group_label>
    <arm_group_label>At risk individuals</arm_group_label>
    <arm_group_label>Cancer patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The three cohorts are: 1) Healthy individuals, 2) At risk individuals and 3) Cancer
        patients.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Meets 1 of the following criteria:

               -  Histologically confirmed pancreatic malignant neoplasm

               -  Serologically or image-confirmed diagnosis of pancreatitis or nonmalignant
                  pancreatic disease

               -  Healthy, at-risk participant meeting the following criteria:

                    -  Smoker, diabetic, and/or has a family history of pancreatic cancer

               -  Healthy participant (no history of cancer)

        PATIENT CHARACTERISTICS:

          -  Not specified

        PRIOR CONCURRENT THERAPY:

          -  Not specified
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel A. Laheru, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</affiliation>
  </overall_official>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2009</study_first_submitted>
  <study_first_submitted_qc>May 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2009</study_first_posted>
  <last_update_submitted>November 17, 2015</last_update_submitted>
  <last_update_submitted_qc>November 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adenocarcinoma of the pancreas</keyword>
  <keyword>recurrent pancreatic cancer</keyword>
  <keyword>stage I pancreatic cancer</keyword>
  <keyword>stage II pancreatic cancer</keyword>
  <keyword>stage III pancreatic cancer</keyword>
  <keyword>stage IV pancreatic cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

